Quince Therapeutics Inc. (NASDAQ: QNCX)
$0.76
+0.0100 ( +1.33% ) 51.0K
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.
Market Data
Open
$0.76
Previous close
$0.75
Volume
51.0K
Market cap
$32.41M
Day range
$0.75 - $0.79
52 week range
$0.63 - $1.70
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 84 | May 13, 2024 |
ars | Annual reports | 1 | Apr 24, 2024 |
def | Proxies and info statements | 21 | Apr 24, 2024 |
pre | Proxies and info statements | 21 | Apr 11, 2024 |
10-k | Annual reports | 112 | Apr 01, 2024 |
3 | Insider transactions | 2 | Feb 15, 2024 |
8-k | 8K-related | 15 | Feb 15, 2024 |
4 | Insider transactions | 1 | Feb 15, 2024 |
4 | Insider transactions | 1 | Feb 02, 2024 |
4 | Insider transactions | 1 | Feb 02, 2024 |